Spark Investment Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-17,500
| Closed | -$154K | – | 325 |
|
|
2020
Q1 | $154K | Buy |
+17,500
| New | +$154K | 0.08% | 249 |
|
|
2018
Q4 | – | Sell |
-56,297
| Closed | -$835K | – | 844 |
|
|
2018
Q3 | $835K | Sell |
56,297
-40,903
| -42% | -$607K | 0.05% | 409 |
|
|
2018
Q2 | $1.64M | Sell |
97,200
-47,400
| -33% | -$797K | 0.1% | 280 |
|
|
2018
Q1 | $3.31M | Buy |
+144,600
| New | +$3.31M | 0.21% | 147 |
|
|
2016
Q4 | – | Sell |
-178,900
| Closed | -$1.81M | – | 913 |
|
|
2016
Q3 | $1.81M | Sell |
178,900
-94,500
| -35% | -$955K | 0.15% | 215 |
|
|
2016
Q2 | $3.07M | Sell |
273,400
-30,100
| -10% | -$338K | 0.29% | 106 |
|
|
2016
Q1 | $4.15M | Sell |
303,500
-7,700
| -2% | -$105K | 0.42% | 50 |
|
|
2015
Q4 | $5.9M | Buy |
311,200
+4,900
| +2% | +$92.9K | 0.75% | 13 |
|
|
2015
Q3 | $5.74M | Buy |
306,300
+134,900
| +79% | +$2.53M | 0.75% | 13 |
|
|
2015
Q2 | $2.55M | Buy |
171,400
+69,100
| +68% | +$1.03M | 0.36% | 76 |
|
|
2015
Q1 | $1.55M | Sell |
102,300
-8,200
| -7% | -$124K | 0.22% | 149 |
|
|
2014
Q4 | $1.47M | Buy |
110,500
+43,700
| +65% | +$581K | 0.25% | 127 |
|
|
2014
Q3 | $839K | Buy |
66,800
+51,900
| +348% | +$652K | 0.13% | 233 |
|
|
2014
Q2 | $150K | Sell |
14,900
-3,800
| -20% | -$38.3K | 0.02% | 525 |
|
|
2014
Q1 | $251K | Buy |
+18,700
| New | +$251K | 0.04% | 483 |
|